Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 119
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

You have mail: Stem Cell messages for fighting liver diseases

The use of stem cells is currently limited by issues including the risk of tumor formation or undesired immune...

How good are North American mosquitoes at spreading Zika virus?

Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

Living Skin Therapeutics

One of the biggest roadblocks to having clear skin is acne, and despite all the effective treatment options...

Backer Badge Funded